
Balloon Catheters Market Report 2026
Global Outlook – By Procedure Type (Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters, Chronic Total Occlusion (CTO) Balloon Catheters), By Product Type (Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Stent Graft Balloon Catheter, Scoring Balloon Catheter), By Distribution Channel (Direct Tender, Third Party Distribution, Other Distribution Channels), By Application (Coronary Artery Disease, Peripheral Artery Disease, Other Applications), By End User (Hospitals, Specialty Centers, Ambulatory Surgery Centers, Other End Users) - Market Size, Trends, And Global Forecast 2026-2035
Balloon Catheters Market Overview
• Balloon Catheters market size has reached to $4.11 billion in 2025 • Expected to grow to $5.25 billion in 2030 at a compound annual growth rate (CAGR) of 5% • Growth Driver: Growth Driven By Rising Popularity Of Minimally Invasive Procedures • Market Trend: Advancing Patient Care With Innovative Clot Removal Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Balloon Catheters Market?
Balloon catheters refer to medical devices used in various medical procedures, particularly in minimally invasive surgeries. These catheters have a small, flexible tube with an inflatable balloon at the tip. They are typically used to treat narrowed or blocked blood vessels, such as in angioplasty procedures, where the balloon is inflated to dilate or open up constricted areas within blood vessels. The main types of balloon catheters are percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, chronic total occlusion (cto) balloon catheters, and microcatheters. Percutaneous transluminal coronary angioplasty (PTCA) balloon catheters refer to a type of medical device used in the procedure known as percutaneous transluminal coronary angioplasty (PTCA). It has various product types, such as normal balloon catheters, drug-eluting balloon catheters, cutting balloon catheters, stent graft balloon catheters, and scoring balloon catheters, and is distributed through direct tender, third-party distribution, and others. It is applied for coronary artery disease, peripheral artery disease, and others and is used by hospitals, specialty centers, ambulatory surgery centers, and others.
What Is The Balloon Catheters Market Size and Share 2026?
The balloon catheters market size has grown strongly in recent years. It will grow from $4.11 billion in 2025 to $4.32 billion in 2026 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to growth in cardiovascular disease prevalence, increased adoption of angioplasty procedures, expansion of catheterization laboratories, availability of advanced interventional cardiology devices, rising clinical expertise in endovascular treatments.What Is The Balloon Catheters Market Growth Forecast?
The balloon catheters market size is expected to see strong growth in the next few years. It will grow to $5.25 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing innovation in balloon catheter coatings, rising demand for outpatient interventional procedures, expansion of minimally invasive treatment indications, growing adoption of precision-guided devices, increasing investment in cardiovascular device R&D. Major trends in the forecast period include increasing adoption of drug-eluting balloon catheters, rising demand for minimally invasive cardiovascular procedures, growing use of high-pressure and scoring balloons, expansion of peripheral artery disease treatments, enhanced focus on procedural precision and safety.Global Balloon Catheters Market Segmentation
1) By Procedure Type: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters, Chronic Total Occlusion (CTO) Balloon Catheters 2) By Product Type: Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Stent Graft Balloon Catheter, Scoring Balloon Catheter 3) By Distribution Channel: Direct Tender, Third Party Distribution, Other Distribution Channels 4) By Application: Coronary Artery Disease, Peripheral Artery Disease, Other Applications 5) By End User: Hospitals, Specialty Centers, Ambulatory Surgery Centers, Other End Users Subsegments: 1) By Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters: Semi-Compliant Balloon Catheters, Non-Compliant Balloon Catheters 2) By Chronic Total Occlusion (CTO) Balloon Catheters: High-Pressure CTO Balloon Catheters, Low-Profile CTO Balloon CathetersWhat Is The Driver Of The Balloon Catheters Market?
The increasing adoption of minimally invasive surgeries is expected to propel the growth of the balloon catheters market going forward. Minimally invasive surgeries (MIS) are a group of surgical procedures performed with minimal incisions, reducing the need for significant cuts or openings in the body. Minimally invasive surgeries (MIS) are increasing due to reduced recovery time, lower risk of complications, and less pain with technological advancements and outpatient procedures. Balloon catheters play a crucial role in enhancing the benefits of minimally invasive surgeries by improving procedures' precision, safety, and comfort while reducing recovery times and hospital stays. For instance, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that they had placed 415 da Vinci surgical systems (robotic surgical systems that use a minimally invasive surgical approach) in the fourth quarter of 2023, representing a 12% increase compared to 2022. Therefore, the increasing adoption of minimally invasive surgeries drives growth in the balloon catheters industry.Key Players In The Global Balloon Catheters Market
Major companies operating in the balloon catheters market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Lepu Medical Technology, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Cook Medical Inc., Biotronik SE & Co. KG, Merit Medical Systems Inc., Asahi Intecc Co. Ltd., Freudenberg Medical LLC, Biomerics, AngioDynamics Inc., Endologix Inc., Raumedic AG, Otsuka Pharmaceutical Factory Inc., AngioScore Inc., CardioFlow, Endocor GmbH, MicroPort Scientific Corporation, Eureka Medical Inc., Neovasc Inc.Global Balloon Catheters Market Trends and Insights
Major companies operating in the balloon catheters market are focusing on developing mechanical thrombectomy (MT) procedure solutions to optimize the removal of blood clots by locally controlling blood flow during these interventions. Mechanical thrombectomy (MT) is a minimally invasive medical procedure used to remove blood clots from blood vessels, typically in cases of ischemic stroke. For instance, in September 2024, CERENOVUS, a neurovascular division of Johnson & Johnson Medical Devices Companies, launched the EMBOGUARD Balloon Guide Catheter in Europe. This device is designed for endovascular procedures, including treating acute ischemic stroke. The EMBOGUARD catheter enhances clot removal by locally controlling blood flow during mechanical thrombectomy procedures. Its use has been associated with increased first-pass recanalization rates, reduced procedure times, and a decreased likelihood of clot fragments causing distal emboli, which can lead to new ischemic events. The EMBOGUARD Balloon Guide Catheter is part of the CERENOVUS Stroke Solutions portfolio, a suite of technologies designed to assist physicians in performing mechanical thrombectomy procedures.What Are Latest Mergers And Acquisitions In The Balloon Catheters Market?
In September 2024, Quasar Medical, a China-based contract development and manufacturing organization operator, acquired Ridgeback Technologies for an undisclosed amount. Through this acquisition, Quasar aims to enhance its ability to deliver customized balloon catheter solutions, accelerate time-to-market, improve production efficiency, and expand its footprint into Galway, Ireland, strengthening its minimally invasive device manufacturing position. Ridgeback Technologies is an Ireland-based provider of catheter balloons intended for the healthcare industry.Regional Outlook
North America was the largest region in the balloon catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Balloon Catheters Market?
The balloon catheter market consists of sales of non-compliant balloon catheters, high-pressure balloon catheters, biliary balloon catheters and urological balloon catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goodsHow is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Balloon Catheters Market Report 2026?
The balloon catheters market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the balloon catheters industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Balloon Catheters Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.32 billion |
| Revenue Forecast In 2035 | $5.25 billion |
| Growth Rate | CAGR of 5.2% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Procedure Type, Product Type, Distribution Channel, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Lepu Medical Technology, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Cook Medical Inc., Biotronik SE & Co. KG, Merit Medical Systems Inc., Asahi Intecc Co. Ltd., Freudenberg Medical LLC, Biomerics, AngioDynamics Inc., Endologix Inc., Raumedic AG, Otsuka Pharmaceutical Factory Inc., AngioScore Inc., CardioFlow, Endocor GmbH, MicroPort Scientific Corporation, Eureka Medical Inc., Neovasc Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
